Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
29,083,598
-
Share change
-
+5,595,078
-
Total reported value
-
$209,401,309
-
Put/Call ratio
-
142%
-
Price per share
-
$7.20
-
Number of holders
-
90
-
Value change
-
+$46,994,951
-
Number of buys
-
66
-
Number of sells
-
36
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q2 2018
As of 30 Jun 2018,
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,083,598 shares.
The largest 10 holders included
STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, D. E. Shaw & Co., Inc., NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, WELLS FARGO & COMPANY/MN, Intellectus Partners, LLC, DEUTSCHE BANK AG\, and MORGAN STANLEY.
This page lists
90
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.